A carregar cotações...
Previsão
O preço-alvo médio dos analistas é € 27,47 (+16,50%). A mediana é € 27,29 (+15,73%).
| Comprar |
9 |
| Manter |
7 |
| Vender |
0 |
Discussões na comunidade
Ainda não há nenhuma discussão sobre este ativo.
Iniciar discussãoNotícias Ir para o feed de notícias
Blacksheep launches in US with prescription glasses from $3.98, targets Warby Parker and Luxottica
Blacksheep, led by CEO Pierre Wizman, is entering the U.S. market offering prescription glasses starting at $3.98 and selling designer frames for $1 with low-cost lenses, claiming on-demand production and minimal margins by cutting out middlemen. Wizman accuses incumbents of massive markups and vows to disrupt Luxottica’s dominance and Warby Parker’s pricing, while Warby Parker defends its value-driven, feature-rich products. Industry peers express skepticism about the feasibility and quality of such low-priced eyewear and note manufacturing and material costs as key differentiators. » Mais em forbes.com
Warby Parker: shareholders elect directors, ratify Ernst & Young and approve compensation
At the annual meeting shareholders elected Dave Gilboa, Youngme Moon and Ronald Williams to the board (term to 2029), ratified Ernst & Young LLP as independent auditors for 2026 and approved, in a non-binding advisory vote, the compensation of the named executive officers. About 95.97% of the voting power was represented. Warby Parker also reported Q1 results with EPS of $0.03 (below expectations) and revenue of $242.45 million (slightly above expectations), and announced an "Intelligent Eyewear" collaboration with Google and Samsung. » Mais em de.investing.com
Warby Parker misses earnings forecast, revenue slightly above expectations
Warby Parker reported Q1 2026 EPS of $0.03 versus $0.15 expected, while revenue of $242.45 million topped expectations of $239.82 million by 1.1%. Retail sales grew 13.6% year‑over‑year, while e‑commerce declined after the discontinuation of the Home-Try-On program. Adjusted gross margin and profitability are under pressure; adjusted EBITDA was $29.6 million (margin 12.2%). The company reaffirmed its full-year revenue guidance of $959–976 million and plans to invest in the planned launch of AI glasses in partnership with Google and Samsung. » Mais em de.investing.com
Warby Parker Q1 2026: revenue rises, new customer growth slows
Warby Parker reported revenue of $242.4 million for Q1 2026, beating analyst expectations, while GAAP earnings per share of $0.03 fell well short of estimates. Active customers grew only 4.8% year‑over‑year, but average revenue per customer rose to $331; adjusted EBITDA margin was 12.2%. The company expanded net 14 stores to 337 locations and reiterated 2026 guidance of $959–976 million in revenue and $117–119 million in adjusted EBITDA, implying expected growth of 10–12%. » Mais em de.investing.com
Warby Parker plans to triple stores to 900 as it expands clinics and launches AI glasses
Warby Parker reported its first full-year net income of $1.6 million on $871.9 million revenue and plans to open about 50 stores in 2026 on the way to a long-term target of at least 900 locations. The company will expand in-store eye exams to 285 sites, roll out 15 new collections including a sport line, and introduce AI-enabled glasses via partnerships with Google and Samsung. Management says the strategy shifts focus from e-commerce disruption to physical expansion, healthcare integration and wearables while maintaining a strong financial position to fund growth. » Mais em forbes.com
Dividendos históricos Dividendos
Todos os indicadores de dividendos Todos os indicadoresDados financeiros da empresa
| (EUR) | setembro de 2026 | YoY |
|---|---|---|
| Receitas | 216,06 mi | 14,38% |
| Ganho bruto | 117,57 mi | 15,03% |
| Ganho líquido | 4,95 mi | 1,17% |
| EBITDA | 18,19 mi | 16,75% |
Dados fundamentais
| Métrica | Valor |
|---|---|
Capitalização bolsista | € 2,72 bi |
Número de ações | 108,8 mi |
Máximo/mínimo de 52 semanas | € 28,88 - € 14,79 |
| Dividendos | Não |
Beta | 1,95 |
PER (PE Ratio) | 457,33 |
PEG (PEG Ratio) | 0,27 |
P/VC (PB Ratio) | 8,48 |
P/V (PS Ratio) | 3,19 |
Perfil da empresa
A Warby Parker Inc. fornece produtos de óptica. Oferece óculos graduados, óculos de sol, lentes fotossensíveis, lentes com filtro de luz azul e lentes de contacto, bem como acessórios, incluindo estojos, kits de lentes com spray antiembaciante, bolsas e spray antiembaciante para lentes. A empresa também oferece exames oculares e testes de visão diretamente aos consumidores através das suas lojas físicas, website e aplicações móveis. Em 16 de maio de 2022, tinha 160 lojas físicas nos Estados Unidos e no Canadá. A empresa era anteriormente conhecida como JAND, Inc. e mudou o seu nome para Warby Parker Inc. em junho de 2021. A Warby Parker Inc. foi constituída em 2009 e tem sede em Nova Iorque, Nova Iorque.
| Nome | WARBY PARKER CL.A -,0001 Aktie |
| CEO | Neil Harris Blumenthal |
| Sede | New York City,
ny EUA |
| Site | |
| Setor | Cuidados de saúde |
| Indústria | Cuidados de saúde: equipamentos e produtos |
| Entrada em bolsa | 29/09/2021 |
| Colaboradores | 4.036 |
Análise aprofundada
Símbolos de ticker
| Bolsa | Símbolo |
|---|---|
NYSE | WRBY |